Any current/future new fundraising through debt or equity?

There is no mention of any current or planned fundraising through debt or equity in the transcript. All the ongoing and planned expansions are being funded through internal accruals. The company pursues asset-light models such as built-to-suit with long-term leases to limit upfront capital expenditure. For example, the Mohali hospital is a 50-year lease model where the developer incurs the project cost except for medical equipment and fit-outs provided by the company. No specific plans for external fundraising were indicated during the call or in the disclosed expansion updates.

Any current/future capex/capital investment/strategic investment?

**Mohali Hospital (250 beds)**: Built-to-suit 2.75 lakh sq.ft. facility on 50-year lease; developer funds land/building; company invests in medical equipment and fit-outs. Commission expected by FY28. **Lucknow Hospital**: Refurbishing existing 250-bed facility; adding 140 beds by end FY24; new 450-bed tower with EC approval, expected completion within 24 months. **Nagpur Hospital**: Adding 25 beds via reconfiguration by Q3 FY25; EC approval filed for 115 additional beds, expected completion in 24 months. **Nanavati Hospital (Phase I)**: New 241-bed structure expected to be completed by

Future growth expectations in sales/revenue/volumes?

Network gross revenue grew 18% YoY and 7% QoQ in Q1 FY25, indicating continued sales growth. Occupancy increased to 77%, with occupied bed days growing ~5% YoY; volume growth expected with capacity expansions. Brownfield expansions (e.g., Lucknow, Nagpur, Shalimar Bagh) will drive volume growth as new beds fill up, with up to 34-35% volume increases noted in expansions. ARPOB growth is expected around 7-10% annually, driven by tariff revisions and higher-end procedures. New hospitals currently have lower ARPOB (~Rs. 45,000) than existing hospitals (~Rs. 80,000), but expected to rise to Rs. 60,

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects steady growth driven by existing and new hospital capacities, with expansions underway in Lucknow, Nagpur, Nanavati, Max Smart, and a built-to-suit project in Mohali. New hospitals like Lucknow and Nagpur are ramping up quickly, contributing significant revenue and EBITDA within three months of acquisition. EBITDA per bed remains strong, and EBITDA per bed of new hospitals is expected to improve as ARPOB (Average Revenue Per Occupied Bed) catches up. Network operating EBITDA grew 12% YoY in Q1 FY25, though marginally down quarter-on-quarter due to new facility costs. PAT wa

Max HealthcareQ1 FY25Healthcare Services

Max Healthcare Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹941P/E: 65.9Market Cap: ₹98.7K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 4

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Network gross revenue grew 18% YoY and 7% QoQ in Q1 FY25, indicating continued sales growth.
Occupancy increased to 77%, with occupied bed days growing ~5% YoY; volume growth expected with capacity expansions.
Brownfield expansions (e.g., Lucknow, Nagpur, Shalimar Bagh) will drive volume growth as new beds fill up, with up to 34-35% volume increases noted in expansions.
ARPOB growth is expected around 7-10% annually, driven by tariff revisions and higher-end procedures.
New hospitals currently have lower ARPOB (~Rs. 45,000) than existing hospitals (~Rs. 80,000), but expected to rise to Rs. 60,000-65,000 within a year.
International patient business is growing faster than other segments, increasing its revenue share.
Expansion plans will increase capacity by several hundred beds over next 1-2 years, supporting volume and revenue growth.
Overall, steady-state growth rates in existing hospitals’ inpatient volumes are expected in high single digits.

Margin guidance

Category 4

The company expects steady growth driven by existing and new hospital capacities, with expansions underway in Lucknow, Nagpur, Nanavati, Max Smart, and a built-to-suit project in Mohali.
New hospitals like Lucknow and Nagpur are ramping up quickly, contributing significant revenue and EBITDA within three months of acquisition.
EBITDA per bed remains strong, and EBITDA per bed of new hospitals is expected to improve as ARPOB (Average Revenue Per Occupied Bed) catches up.
Network operating EBITDA grew 12% YoY in Q1 FY25, though marginally down quarter-on-quarter due to new facility costs.
PAT was Rs. 316 crore in Q1 FY25 with expectations of substantial improvements ahead, supported by equity infusion to reduce finance costs.
ARPOB and inpatient volume growth expected to be in the mid-to-high single digits, aided by higher-end clinical mix and tariff revisions.
Management targets growth in international business segments, expected to outpace domestic growth.
Expansion and growth investments are being funded primarily through internal accruals, maintaining healthy cash flow generation.

See what Max Healthcare management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no mention of any current or planned fundraising through debt or equity in the transcript.
All the ongoing and planned expansions are being funded through internal accruals.
The company pursues asset-light models such as built-to-suit with long-term leases to limit upfront capital expenditure.
For example, the Mohali hospital is a 50-year lease model where the developer incurs the project cost except for medical equipment and fit-outs provided by the company.
No specific plans for external fundraising were indicated during the call or in the disclosed expansion updates.

Order book

The transcript does not explicitly mention any details about the current or expected order book or pending orders related to the company or its projects. However, it provides updates on various ongoing and upcoming hospital expansion projects and their statuses, which could indirectly reflect the company's pipeline: - Lucknow hospital: Refurbishment underway; 140 new beds finishing work started; environmental clearance received for a 450-bed tower, expected completion within 24 months. - Nagpur hospital: Adding 25 beds by Q3 FY25; environmental clearance applied for 115 additional beds; project completion within 24 months. - Nanavati (Phase I): Hospital structure expected by end of the fiscal year; project on schedule. - Max Smart (Saket Complex): Project fast-tracked, expected completion by Q1 FY26. - Mohali (155 beds): On schedule, completion expected by Q1 FY26. - Sector 56, Gurgaon (300 beds, Phase I): First phase expected by Q2 FY26. - Patparganj (250 beds, Phase I): Tendering in progress; received necessary approvals. No specific numeric details on order book or pending orders are provided.

See what Max Healthcare management said on order book — free account, 30 seconds.

Capex plans

Yes

Mohali Hospital (250 beds): Built-to-suit 2.75 lakh sq.ft. facility on 50-year lease; developer funds land/building; company invests in medical equipment and fit-outs. Commission expected by FY28.
Lucknow Hospital: Refurbishing existing 250-bed facility; adding 140 beds by end FY24; new 450-bed tower with EC approval, expected completion within 24 months.
Nagpur Hospital: Adding 25 beds via reconfiguration by Q3 FY25; EC approval filed for 115 additional beds, expected completion in 24 months.
Nanavati Hospital (Phase I): New 241-bed structure expected to be completed by FY25 end; project on schedule.
Max Smart (Saket Complex): 375-bed steel structure building fast-tracked; completion expected by Q1 FY26.
Expansion mostly funded through internal accruals, following an asset-light strategy minimizing development risks.

Track Max Healthcare — get its next earnings analysis in your feed

How does Max Healthcare rank vs peers in Healthcare Services?

Pro feature

ThisMax Healthcare

Rev 3Mar 4

See where Max Healthcare sits in Healthcare ServicesSee which companies these are, and every other name in the sector.Open rankings

How does Max Healthcare rank in Healthcare Services?

Compare Max Healthcare against every Healthcare Services company (Q1 FY25) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

What Max Healthcare's management said in earlier quarters

Others in Healthcare Services this season

KMC Speciality Hospitals (India) Ltd (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
KMC Speciality Hospitals (India) Ltd (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
Suven Life Sciences Ltd (Q1 FY22)
The provided pages of the Suven Life Sciences investor presentation do not contain any specific revenue, sales, or volume figures for any quarter. Key concall…
Vimta Labs Ltd (Q3 FY25)
Q3 FY25 Revenue from Operations: ₹899 Mn . Key concall takeaways from Vimta Labs Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

Compare:vs Apollo Hospitals Enterprise Ltd vs Manipal Health vs Aster DM Quality

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →